학술논문
MetGastric: A randomized phase III study of onartuzumab (MetMAb) in combination with mFOLFOX6 in patients with metastatic HER2-negative and MET-positive adenocarcinoma of the stomach or gastroesophageal junction
Document Type
Journal
Author
Source
Subject
Language
English
ISSN
15277755